To date, approximately 200 different mutations in the MECP2 gene have been identified. We analyzed the entire coding sequence of the MECP2 gene and the X-chromosome inactivation pattern in 42 sporadic cases of Rett syndrome. Of the 42 patients, 30 had pathogenic mutations, including 14 different mutations: 9 missense mutations, 4 nonsense mutations, and 1 frameshift mutation. One was a novel mutation (S134P). There was a tendency for patients who had a nonsense mutation in the transcriptional repression domain region to show earlier onset of regression and more severe language retardation than patients with a mutation in the methyl-CpG binding domain region. However, the parameters of clinical severity were variable among patients with the same type of mutation, depending on the pattern of X-chromosome inactivation. This study suggests that the X-chromosome inactivation pattern can modify the phenotype of Rett syndrome, which is primarily determined by the type and site of MECP2 gene
mutation analysis on patients of various ethnicities, with almost 200 different mutations reported in up to 85 to 90% of cases of classic Rett syndrome.^''' We also previously reported the results of a mutation spectrum in 20 Korean girls with Rett syndrome. ' In the current study, we extended our previous results by analyzing the genotype-phenotype correlation according to mutation type and X-chromosome inactivation pattern. These results should help the assessment of the mutation spectrum in our population and might provide insight into the effect of mutation on the Rett syndrome phenotype.
PATIENTS AND METHODS

Subjects
Forty-two sporadic cases of Rett syndrome were included in this study. To validate the diagnosis, we used the internationally accepted criteria specified by the Rett Syndrome Diagnostic Criteria Work Group."' Following normal development up to the age of 6 to 18 months, all patients demonstrated developmental arrest or regression thereafter. All of the patients met at least eight of the nine necessary criteria and were classified as having typical Rett syndrome. Severity scores were graded based on hand and motor performance and language skills at the age of 5 years (Table 1) . Clinical characteristics such as seizure, scoliosis, abnormal breathing, and onset age at regression were additionally included in the sever- Table 2 ). The severity scores could not be measured in 21 patients because they were less than 5 years old at the last follow-up.
Mutational Analysis
Total genomic DNA was extracted from peripheral blood leukocytes by standard procedures." We amplified three exons of the MECP2 gene by polymerase chain reaction (PCR) using Taq DNA polymerase (TaKaRa Taq™, Takara Shuzuo Co., Ltd). Six previously described primer pairs were used to amplify three exons. '^ PCR conditions were initial denaturation at 94°C for 2 minutes, followed by 30 cycles of denaturation at 94°C for 20 seconds, annealing at 59°C for 20 seconds, extension at 72°C for 1 minute, and a final extension step at 72°C for 10 minutes. We purified the PCR products using a PCR Purification Kit (QIA quick™, Qiagen GmbH, Hilden, Germany) and sequenced them directly using dye terminator chemistry and an automated sequencer (ABI Pdsm 310, Perkin Elmer, Applied Biosystems, Foster City, CA). One hundred alleles from normal Korean female controls were screened by singlestrand conformational analysis for polymorphisms.
X-Chromosome Inactivation Assay
To determine the pattern of X-chromosome inactivation, we performed methylation-specific allele PCR at the human androgen receptor locus (HUMARA) on the X chromosome, as previously described by Kubota et al.'* We defined skewed X-chromosome inactivation as greater than 70% expression of one allele of androgen receptor.
Genotype-Phenotype Correlation
Clinical features and severity according to the type of mutation and pattern of X-chromosome inactivation in the same mutation type were also analyzed.
RESULTS
Clinical Features
Of the 42 patients included, 21 met all of the nine necessary clinical criteria. The remaining 21 met only eight of the nine criteria because they were less than 5 years old. The average age at diagnosis was 3 years and 7 months, and the average age at regression commencement was 1 year and 2 months old. Seventeen patients had never achieved any speech development, such as single words such as "mama" or "papa." All patients revealed abnormal electroencephalographic findings, including background abnormality with or without generalized or partial epileptiform discharges. Clinical seizures were observed in 25 patients (59.5%), including infantile spasms in 3 cases. All patients except one were well controlled with antiepilepsy drugs. Twelve patients had sleep disturbance and an irregular sleep pattern before 1 year of age. Sixteen patients showed an abnormal breathing pattern such as irregular breathing, hyperventilation with air swallowing, and intemnittent apnea, two of whom had moderate abdominal distention without functional disturbances (Table 3) .
Mutation Analysis
Of the 42 patients, 30 (71.4%) had pathogenic mutations of 14 distinct types (Table 4) : 9 missense mutations (D97Y, LIOOV, R133C, S134P, P152R, T158M, A279V, R306C, P322L), 4 nonsense mutations (R168X, R255X, R270X, R294X), and 1 frameshift mutation (a 41 bp deletion at 1157-1197). We also found four silent mutations (C753T, C834T, G1176A, C1326T). Mutations most commonly occurred in CpG hotspots of methyl-CpG binding domains or transcriptional repression domains (17/30; 73%). Eighty-six percent of them had a C-to-T transition, eight of which were recurrent. All except one have been reported previously in other races. To confirm that S134P is a novel pathogenic mutation, we analyzed DNA in 100 alleles of normal females. We found no identifiable pathogenic mutation in the MECP2 gene in 12 (28.6%) of them.
X-Chromosome Inactivation Assay X-chromosome inactivation assays were performed in 15 patients with identifiable pathogenic mutations ( Table 5) . Seven patients (46.7%) had skewed X-chromosome inactivation. Six of those with skewing were highly associated with nonsense mutations. 
Phenotype-Genotype Correlation
We evaluated the severity scores of 21 patients who were at least 5 years of age. Mean severity scores were 8.3 and 8.4 in the patients with nonsense and missense mutations, respectively, and 7.8 in the patients without mutation. The patients with nonsense mutations tended to show more severe language retardation (10/15; 66.7%) and earlier age at regression onset (13 months old) than those with missense mutations (6/15; 40%; 15 months old). Otherwise, there was no significant difference in clinical severity according to types of mutation. Comparing within the same type of mutation (see Table 5 ), nonsense mutants with skewing showed a milder phenotype in some patients, whereas the missense mutation with skewing showed a more severe phenotype in another patient (case 21).
DISCUSSION
Rett syndrome is a neurodevelopmental disorder, occurring predominantly in females, with an incidence of 1 in 10,000 to 15,000 female births."* It is the second most common cause of female mental retardation. To evaluate the frequency and types of MECP2 gene mutations in the Korean population, we studied 42 sporadic cases of typical Rett syndrome. We identified 14 distinct mutations in 30 (71.4%) patients. Preferential clustering of missense mutations in the methyl-CpG binding domain region and nonsense mutations in the transcriptional repression domain concurs with previous reports by other groups.'''^"'^"'"^' The most common mutations, hot spots of the MECP2 gene, in Koreans are T158M, R168X, and R255X, constituting 46.7% of mutations. In accordance with the prediction by Wan et al,^2 6 (86.7%) of the 30 patients with MECP2 mutations had point mutations resulting from C-to-T substitutions in our series. These data support the proposition that a C-to-T transition in an Arg codon is the most common mutation of the MECP2 gene in patients with Rett syndrome, and, further, it is hypermutable. C763T  C502T  C916T  C1326T  C880T  None  C473T  C763T  C473T  C298G  C808T  C473T  None  G1176A  C397T  None  C763T  G289T  C473T  C502T  C763T  C753T  C836T  C502T  C401T  C834T  C965T  C455G  C880T  C836T  C763T  C473T According to growing reports demonstrating phenotype-genotype correiation, two different genetic factors are likely to influence the phenotype in Rett syndrome.'''^^^" However, there does not appear to be a clear correlation between the presence of a specific phenotype or severity and the type or location of the mutation. Recently, Huppke et al reported an interesting phenotype-genotype correlation in large study populations, that is, all mutations that impair the nuclear localization signal are associated with a more severe phenotype.^'' All except one of the seven patients in our study with mutation in the transcriptional repression domain or nuclear localization signal (R255X and R270X), however, showed relatively mild severity. Because each clinical feature evolves as time passes, it is difficult to determine the precise phenotype, and more follow-up periods will be needed under the standardized evaluation system. We also plan to extend this study by following up after a longer time period, bcised on the standardized phenotype scoring system proposed by an international Rett syndrome multicenter research group.^^ When the severity scores were compared between patients with missense and nonsense mutations, the onset age at regression was earlier and language retardation was more severe with nonsense mutations in the transcriptional repression domain regions, although mean severity scores showed no differences. Therefore, there was a tendency for patients with nonsense mutations in transcriptional repression domains to show more severe clinical phenotypes, although not in all features of Rett syndrome, than those with missense mutations in methyl-CpG binding domains. If we exclude a patient (patient 2) with deletion within the hot spot, which was considered to be distinctly more mildly affected in another recent study,^*' the difference in severity becomes more significant.
Most girls with a mutation in our series exhibited a higher degree of nonrandom patterns of X-chromosome inactivation. We had findings similar to those of a recent report by Weaving et al demonstrating a higher incidence of skewing in mutant groups than would be expected in normal female populations, especially in patients with truncating mutations.^^ These are additional supportive evidence that X-chromosome inactivation might play a crucial role in the pathogenic mechanism of Rett syndrome.
Comparing within patients with the same truncating mutations and skewed inactivation, most of them showed a moderate degree of severity, but one of them preserved the motor function ability of independent walking and had relatively better hand function. One patient (case 21) with a T158M mutation associated with skewed X-chromosome inactivation showed a more severe phenotype than other patients with the same mutation. This observation supports the notion that the X-chromosome inactivation pattern, depending on which aUele was being preferentially silenced, can modify the phenotype of Rett syndrome in certain clinical features, primarily determined by the site and location of the MECP2 gene. Further studies of the expression of other X-linked diseases will clarify the influence olMECP2 defects for X-chromosome inactivation.
We could not find any detectable mutations in 28.5% of our cases with typical clinical features of Rett syndrome. We are in the process of completing further extended studies of these patients, as well as those with atypical Rett syndrome, Rettlike features, or undetermined mental retardation.
We have confirmed that MECP2 is the most important gene responsible for Rett syndrome in Korean patients. Three of the most common mutations (T158M, R168X, and R255X), a hot spot in our population and constituting about half of the cases, were identified. The results will contribute to reliable early diagnosis of Rett syndrome in female patients with neurodevelopmental disorders in Korea. According to our data, the Rett syndrome phenotype was determined primarily by the site and location of mutations, although X-chromosome inactivation might play an important role in modifying the phenotype. Despite accumulated R168X  R168X  R168X  R168X  R255X  R255X  R255X  R255X  R255X  R270X  R270X  R294X  R294X  R294X   D97Y  L100V  R133C  S134P  P152R  T158IV1  T158M  T158IVI  T158M  T158M  A279V  A279V  A279V  R306C data over the last several years, the pathogenesis of Rett syndronie and the function of MECP2 are still unclear. Further studies of functional and gene expression and phenotypegenotype correlation in larger study populations will provide answers to some of the above questions.
